Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Protagonist Therapeutics
PTGX
$8.59B
| $942K | ﹤0.01% |
32,567
-181,400
| -85% | -$4.94M |
|
2527
GrafTech
EAF
$187M
| $933K | ﹤0.01% |
67,610
-53,800
| -44% | -$839K |
|
2528
iShares Core US REIT ETF
USRT
$4.65B
| $931K | ﹤0.01% |
17,300
+7,700
| +80% | +$408K |
|
2529
Marten Transport
MRTN
$1.2B
| $929K | ﹤0.01% |
50,266
+20,766
| +70% | +$399K |
|
2530
Brighthouse Financial
BHF
$3.57B
| $928K | ﹤0.01% |
+18,000
| New | +$894K |
|
2531
Vanguard Industrials ETF
VIS
$8.2B
| $928K | ﹤0.01% |
3,800
-300
| -7% | -$68.1K |
|
2532
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.45B
| $925K | ﹤0.01% |
17,600
-9,800
| -36% | -$484K |
|
2533
Invesco Aerospace & Defense ETF
PPA
$8.37B
| $924K | ﹤0.01% |
9,100
-15,300
| -63% | -$1.45M |
|
2534
MaxLinear
MXL
$6.11B
| $922K | ﹤0.01% |
49,391
-204,013
| -81% | -$4.07M |
|
2535
Sight Sciences
SGHT
$300M
| $922K | ﹤0.01% |
174,656
+97,256
| +126% | +$457K |
|
2536
Myomo
MYO
$41.3M
| $921K | ﹤0.01% |
281,700
+88,100
| +46% | +$319K |
|
2537
Schwab U.S Small- Cap ETF
SCHA
$22.6B
| $921K | ﹤0.01% |
+37,400
| New | +$876K |
|
2538
First US Bancshares
FUSB
$92.1M
| $919K | ﹤0.01% |
99,221
-2,800
| -3% | -$27.7K |
|
|
SCTL
2539
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $918K | ﹤0.01% |
850,317
+19,100
| +2% | +$12.3K |
|
2540
Solid Biosciences
SLDB
$775M
| $916K | ﹤0.01% |
68,771
+30,700
| +81% | +$287K |
|
2541
Sibanye-Stillwater
SBSW
$6.26B
| $915K | ﹤0.01% |
+194,200
| New | +$892K |
|
2542
Cumberland Pharmaceuticals
CPIX
$94.2M
| $912K | ﹤0.01% |
542,663
-7,200
| -1% | -$14.4K |
|
2543
Moog Inc Class B
MOG.B
$12.5B
| $911K | ﹤0.01% |
5,800
-100
| -2% | -$14.4K |
|
2544
US Physical Therapy
USPH
$1.2B
| $908K | ﹤0.01% |
8,049
-7,600
| -49% | -$759K |
|
2545
Rallybio
RLYB
$85.2M
| $903K | ﹤0.01% |
+61,013
| New | +$850K |
|
2546
Zevra Therapeutics
ZVRA
$580M
| $901K | ﹤0.01% |
155,400
-15,100
| -9% | -$92.8K |
|
2547
Fidelity Wise Origin Bitcoin Fund
FBTC
$11.8B
| $900K | ﹤0.01% |
+14,500
| New | +$694K |
|
2548
Avantis International Equity ETF
AVDE
$18.2B
| $899K | ﹤0.01% |
+14,100
| New | +$858K |
|
|
WKME
2549
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $899K | ﹤0.01% |
104,500
+41,700
| +66% | +$406K |
|
2550
Mistras Group
MG
$490M
| $897K | ﹤0.01% |
93,800
+9,500
| +11% | +$79.2K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.